RYCRX | VGSIX | RYCRX / VGSIX | |
Total Expense Ratio | 2.41 | 0.27 | 893% |
Annual Report Gross Expense Ratio | 2.44 | 0.27 | 904% |
Fund Existence | 21 years | 29 years | - |
Gain YTD | 2.747 | 4.920 | 56% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.01M | 63.8B | 0% |
Annual Yield % from dividends | 0.98 | 3.75 | 26% |
Returns for 1 year | 5.80 | 8.10 | 72% |
Returns for 3 years | 4.81 | 9.41 | 51% |
Returns for 5 years | 33.81 | 41.03 | 82% |
Returns for 10 years | 37.56 | 63.27 | 59% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
APCB | 29.40 | 0.02 | +0.07% |
ActivePassive Core Bond ETF | |||
XTR | 29.03 | N/A | N/A |
Global X S&P 500® Tail Risk ETF | |||
BIB | 52.55 | -0.07 | -0.14% |
ProShares Ultra Nasdaq Biotechnology | |||
FICS | 39.48 | -0.15 | -0.38% |
First Trust Intl Developed Cap Strth ETF | |||
IJR | 112.91 | -1.24 | -1.09% |
iShares Core S&P Small-Cap ETF |